|
Myocardial cardiomyopathy disease
Citations 1-10 of 67 total displayed.
|
Most recent content
(1 Dec 2009):
|
- Original Articles
Prorenin Contributes to Angiotensin Peptide Formation in Transgenic Rats With Rat Prorenin Expression Targeted to the Liver
- Duncan J. Campbell, Habib Karam, Joël Ménard, Patrick Bruneval, and John J. Mullins
Hypertension 2009;54:1248-1253; published online before print as doi:10.1161/HYPERTENSIONAHA.109.138495
[Abstract]
[Full text]
|
Past content
(since Jan 2000):
|
- Scientific Contributions
Prorenin Contributes to Angiotensin Peptide Formation in Transgenic Rats With Rat Prorenin Expression Targeted to the Liver
- Duncan J. Campbell, Habib Karam, Joël Ménard, Patrick Bruneval, and John J. Mullins
Hypertension published October 19, 2009, doi:10.1161/HYPERTENSIONAHA.109.138495
[Abstract]
- Editorial Commentaries
Have No Fear, MitoQ10 Is Here
- John C. Barbato
Hypertension 2009;54:222-223; published online before print as doi:10.1161/HYPERTENSIONAHA.109.135533
[Full text]
- Editorial Commentary
Have No Fear, MitoQ10 Is Here
- John C. Barbato
Hypertension published July 6, 2009, doi:10.1161/HYPERTENSIONAHA.109.135533
[Abstract]
- Original Articles
Metallothionein Abrogates GTP Cyclohydrolase I Inhibition–Induced Cardiac Contractile and Morphological Defects: Role of Mitochondrial Biogenesis
- Asli F. Ceylan-Isik, Kelly K. Guo, Edward C. Carlson, Jamie R. Privratsky, Song-Jie Liao, Lu Cai, Alex F. Chen, and Jun Ren
Hypertension 2009;53:1023-1031; published online before print as doi:10.1161/HYPERTENSIONAHA.108.123422
[Abstract]
[Full text]
- Scientific Contributions
Metallothionein Abrogates GTP Cyclohydrolase I Inhibition–Induced Cardiac Contractile and Morphological Defects. Role of Mitochondrial Biogenesis
- Asli F. Ceylan-Isik, Kelly K. Guo, Edward C. Carlson, Jamie R. Privratsky, Song-Jie Liao, Lu Cai, Alex F. Chen, and Jun Ren
Hypertension published April 27, 2009, doi:10.1161/HYPERTENSIONAHA.108.123422
[Abstract]
- Brief Reviews
Modulation of the Endocannabinoid System in Cardiovascular Disease: Therapeutic Potential and Limitations
- Pál Pacher, Partha Mukhopadhyay, Rajesh Mohanraj, Grzegorz Godlewski, Sándor Bátkai, and George Kunos
Hypertension 2008;52:601-607; published online before print as doi:10.1161/HYPERTENSIONAHA.105.063651
[Full text]
- Brief Reviews
Modulation of the Endocannabinoid System in Cardiovascular Disease. Therapeutic Potential and Limitations
- Pál Pacher, Partha Mukhopadhyay, Rajesh Mohanraj, Grzegorz Godlewski, Sándor Bátkai, and George Kunos
Hypertension published September 8, 2008, doi:10.1161/HYPERTENSIONAHA.105.063651
[Abstract]
- Original Articles
Pharmacological Inhibition of -Protein Kinase C Attenuates Cardiac Fibrosis and Dysfunction in Hypertension-Induced Heart Failure
- Koichi Inagaki, Tomoyoshi Koyanagi, Natalia C. Berry, Lihan Sun, and Daria Mochly-Rosen
Hypertension 2008;51:1565-1569; published online before print as doi:10.1161/HYPERTENSIONAHA.107.109637
[Abstract]
[Full text]
- Scientific Contributions
Pharmacological Inhibition of -Protein Kinase C Attenuates Cardiac Fibrosis and Dysfunction in Hypertension-Induced Heart Failure
- Koichi Inagaki, Tomoyoshi Koyanagi, Natalia C. Berry, Lihan Sun, and Daria Mochly-Rosen
Hypertension published April 14, 2008, doi:10.1161/HYPERTENSIONAHA.107.109637
[Abstract]
|
|